Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

37/433 Matches for
“Children non-alcoholic fatty liver disease”

“Children non-alcoholic fatty liver disease” Clear all

  1. Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children.

    Rubio A et al. · J Pediatr Gastroenterol Nutr · 2009 Match 100

    …Progressive liver injury is a concern in HIV-infected children exposed to…

    FibroTest HIV

  2. Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study.

    Flores-Calderón J et al. · Ann Hepatol · 2012 Match 99

    …liver fibrosis. ### Material And Methods 68 children with chronic liver disease requiring…

    FibroTest

  3. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.

    Poinsot P et al. · J Clin Lipidol · 2017 Match 98

    …Children present severe fatty liver disease with early cirrhosis. Before enzyme replacement…

    FibroTest Metabolic

  4. Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.

    El-Shabrawi MH et al. · Eur J Gastroenterol Hepatol · 2010 Match 96

    …Liver biopsy, because of its limitations and risks, might be considered an…

    ActiTest FibroTest HCV

  5. Biomarkers for liver disease in urea cycle disorders.

    Nagamani SCS et al. · Mol Genet Metab · 2021 Match 95

    …liver disease. Thus, we systematically evaluated the potential utility of several non…

    ActiTest FibroTest Other

  6. Non-invasive Investigations for the Diagnosis of Fontan-Associated Liver Disease in Pediatric and Adult Fontan Patients.

    Fidai A et al. · Front Cardiovasc Med · 2017 Match 94

    Fontan-associated liver disease (FALD) is a serious complication related to the…

    FibroTest Other

  7. Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.

    Wilson TG et al. · Int J Cardiol · 2018 Match 92

    ### Background Hepatic and renal dysfunction have been observed in survivors of the…

    FibroTest Other

  8. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

    Match 91

    FibroTest HBV

  9. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.

    European Association for the Study of the Liver (EASL) et al. · Obes Facts · 2016 Match 90

    FibroTest SteatoTest Metabolic

  10. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.

    Wu FM et al. · J Heart Lung Transplant · 2017 Match 88

    …Further studies are needed to guide strategies for surveillance of liver disease…

    FibroTest

  11. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.

    Więcek S et al. · Mediators Inflamm · 2020 Match 87

    Changes in the liver and bile ducts observed in patients diagnosed with…

    ActiTest FibroTest Other

  12. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

    Zelber-Sagi S et al. · World J Gastroenterol · 2013 Match 86

    …and quantification in nonalcoholic fatty liver disease (NAFLD). ### Methods Cross-sectional study…

    SteatoTest Metabolic

  13. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.

    Minville C et al. · Chest · 2014 Match 84

    …contributing factor for nonalcoholic fatty liver disease (NAFLD). NAFLD severity and its…

    FibroTest NashTest SteatoTest Metabolic

  14. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

    Vilar-Gomez E et al. · J Hepatol · 2018 Match 83

    …assessment of non-alcoholic fatty liver disease (NAFLD). Since liver biopsy is…

    FibroTest Metabolic

  15. Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19.

    Deckmyn O et al. · Biomedicines · 2022 Match 82

    In patients with non-alcoholic fatty liver disease (NAFLD) with or without…

    FibroTest Metabolic

  16. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

    European Association For The Study Of The Liver · J Hepatol · 2012 Match 80

    ActiTest FibroTest HBV

  17. Noninvasive evaluation of NAFLD.

    Castera L et al. · Nat Rev Gastroenterol Hepatol · 2013 Match 79

    …developing complications of end-stage liver disease. Although it lacks sensitivity, ultrasonography…

    ActiTest FibroTest NashTest SteatoTest +1

  18. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Key publication

    Halfon P et al. · Gastroenterol Clin Biol · 2008 Match 78

    …CHB), alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD…

    FibroTest Alcohol HBV HCV +2

  19. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

    Sadler MD et al. · Can J Gastroenterol Hepatol · 2015 Match 76

    ### Background Liver disease is the third leading cause of mortality in patients…

    FibroTest Other

  20. Biomarkers of liver fibrosis.

    Poynard T et al. · Adv Clin Chem · 2008 Match 75

    …liver disease, hepatitis C, hepatitis B, alcoholic or nonalcoholic fatty liver disease…

    ActiTest FibroTest SteatoTest Alcohol +5

  21. The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women.

    Simental-Mendía LE et al. · Ann Hepatol · 2016 Match 73

    …Given that early identification of non-alcoholic fatty liver disease (NAFLD) is…

    NashTest SteatoTest Metabolic

  22. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis.

    Friedrich-Rust M et al. · BMC Gastroenterol · 2010 Match 72

    …patients with chronic liver disease, who received a liver biopsy, transient elastography…

    FibroTest HBV HCV Other

  23. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.

    Poynard T et al. · J Hepatol · 2012 Match 71

    …non-alcoholic fatty liver disease (NAFLD), and 218 with alcoholic fatty liver…

    FibroTest Alcohol HBV HCV +1

  24. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Key publication

    Poynard T et al. · Gastroenterol Clin Biol · 2008 Match 69

    …the interpretation of non-invasive biomarkers in liver fibrosis. A scoring system…

    ActiTest FibroTest SteatoTest Alcohol +5

  25. Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

    Peta V et al. · World J Hepatol · 2025 Match 68

    …enrolled 103 patients for whom liver biopsy, hepatic elastography results, and laboratory…

    ActiTest FibroTest AIH

  26. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B.

    Poynard T et al. · Gastro Hep Adv · 2022 Match 67

    ### Background And Aims The liver cancer risk test (LCR1-LCR2) is a…

    FibroTest LCR1 LCR2 Surveillance-FibroTest +1

  27. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Key publication

    European Association for Study of Liver et al. · J Hepatol · 2015 Match 65

    FibroTest Alcohol HBV HCV +3

  28. Personalized management of cirrhosis by non-invasive tests of liver fibrosis.

    Wong GL et al. · Clin Mol Hepatol · 2015 Match 64

    …liver biopsy. In this review, we discuss the application of these non…

    FibroTest Alcohol HBV HCV +1

  29. [Biomarkers for liver fibrosis: advances, advantages and disadvantages].

    Cequera A et al. · Rev Gastroenterol Mex · 2014 Match 63

    …depending on etiology and disease stage. Liver biopsy, traditionally regarded as the…

    FibroTest HCV

  30. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

    Ahmad W et al. · Virol J · 2011 Match 61

    …liver histological stages, an assessment of the disease development based on non…

    FibroTest HCV

  31. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.

    Terrier B et al. · J Hepatol · 2011 Match 60

    …Serum levels of 25(OH)D3 were also significantly correlated with liver…

    ActiTest FibroTest HCV HIV

  32. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Key publication

    AASLD/IDSA HCV Guidance Panel · Hepatology · 2015 Match 59

    ActiTest FibroTest HCV

  33. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Key publication

    Myers RP et al. · Can J Gastroenterol · 2012 Match 57

    Chronic hepatitis C remains a significant medical and economic burden in Canada…

    FibroTest HCV

  34. Silymarin in non alcoholic fatty liver disease.

    Cacciapuoti F et al. · World J Hepatol · 2013 Match 56

    …silybum marianum on non alcoholic fatty liver disease (NAFLD). ### Methods In 72…

    SteatoTest Metabolic

  35. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.

    Stevenson M et al. · Health Technol Assess · 2012 Match 55

    …development of alcohol-related liver disease (ALD). Liver biopsy may be used…

    FibroTest Alcohol

  36. Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

    Lee S et al. · World J Gastroenterol · 2014 Match 53

    …Liver biopsy is the reference standard for assessment of liver fibrosis. However…

    FibroTest HBV

  37. Ministère des Affaires Sociales et de la Santé Key publication

    Match 52

    FibroTest HBV HCV

Showing the full result list. The page is server-rendered and not paginated.